Tweet
<img alt="" height="1" width="1" />
Forest touts new products as Lexapro expiry looms
Reuters
NEW YORK, Jan 7 (Reuters) - Forest Laboratories Inc (FRX.N) is building a significant product portfolio to help cushion the blow from losing sales of its biggest product in the coming years, executives said on Thursday. ...
FDA Staff Against New Use of Forest Labs DrugABC News
FDA Review Recommends Against Forest Drug For Heart FailureWall Street Journal
FDA Likely to Withhold Approval for Forest Labs' Bystolic (FRX)Comtex Smartrend
News & Observer
all 64 news articles »
More...